Literature DB >> 8394033

Role of thoracic radiotherapy in small cell lung cancer.

J S Tobias.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8394033      PMCID： PMC464570          DOI： 10.1136/thx.48.6.587

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  9 in total

1.  A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Authors:  J P Pignon; R Arriagada; D C Ihde; D H Johnson; M C Perry; R L Souhami; O Brodin; R A Joss; M S Kies; B Lebeau
Journal:  N Engl J Med       Date:  1992-12-03       Impact factor: 91.245

2.  PROGNOSTIC SIGNIFICANCE OF EXTENT OF TUMOR REGRESSION AT COMPLETION OF RADIATION THERAPY.

Authors:  H SUIT; R LINDBERG; G H FLETCHER
Journal:  Radiology       Date:  1965-06       Impact factor: 11.105

3.  The superior vena cava obstruction syndrome in bronchogenic carcinoma; pathologic physiology and therapeutic management.

Authors:  B ROSWIT; G KAPLAN; H G JACOBSON
Journal:  Radiology       Date:  1953-11       Impact factor: 11.105

4.  Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of bronchus. Ten-year follow-up.

Authors:  W Fox; J G Scadding
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

5.  Is thoracic radiation therapy necessary for patients with limited-stage small cell lung cancer? No.

Authors:  M H Cohen
Journal:  Cancer Treat Rep       Date:  1983-03

6.  Is chest radiotherapy necessary in any or all patients with small cell carcinoma of the lung? Yes.

Authors:  R W Byhardt; J D Cox
Journal:  Cancer Treat Rep       Date:  1983-03

7.  Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial.

Authors:  R L Souhami; D M Geddes; S G Spiro; P G Harper; J S Tobias; B S Mantell; F Fearon; I Bradbury
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-02

8.  Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

Authors:  N Murray; P Coy; J L Pater; I Hodson; A Arnold; B C Zee; D Payne; E C Kostashuk; W K Evans; P Dixon
Journal:  J Clin Oncol       Date:  1993-02       Impact factor: 44.544

9.  Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy.

Authors:  P G Harper; R L Souhami; S G Spiro; D M Geddes; M Guimaraes; F Fearon; J F Smyth
Journal:  Cancer Treat Rep       Date:  1982-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.